TY - JOUR
T1 - Progesterone and Estradiol Levels Associated with Concussion and Clinical Outcomes and Recovery in Female Athletes and Cadets
AU - CARE Consortium Investigators
AU - Goeckner, Bryna D.
AU - Huber, Daniel L.
AU - Van Bortel, Kearnin
AU - Gill, Jessica M.
AU - Mannix, Rebekah
AU - Master, Christina L.
AU - Brett, Benjamin L.
AU - Pasquina, Paul F.
AU - Broglio, Steven P.
AU - Mcallister, Thomas W.
AU - Harezlak, Jaroslaw
AU - Mccrea, Michael A.
AU - Meier, Timothy B.
AU - Giza, Christopher C.
AU - Goldman, Joshua T.
AU - Brooks, M. Alison
AU - Duma, Stefan M.
AU - Roach, Megan H.
AU - Cameron, Kenneth L.
AU - McGinty, Gerald
AU - Jackson, Jonathan C.
AU - Saykin, Andrew J.
AU - Mihalik, Jason P.
N1 - Publisher Copyright:
Copyright © 2024 by the American College of Sports Medicine.
PY - 2025/3/1
Y1 - 2025/3/1
N2 - Introduction Female athletes are underrepresented in concussion research, and few studies have investigated associations of ovarian hormones with concussion outcomes. This study explored associations of concussion with levels and variability of progesterone, estradiol, and their ratio (P/E) and examined relationships of hormone levels with clinical measures and recovery after concussion in CARE Consortium female athletes and cadets. Methods Female participants enrolled (n = 749) at pre-injury baseline. Participants with concussion (mean age, 19.34 yr; n = 130, 90 athletes, 40 nonathlete cadets) completed one or more visits at nonstandardized times of day: immediately post-injury, 24 h post-injury, upon initiating the return-to-play protocol (Init RTP), and 7 d following unrestricted return-to-play (PRTP). Controls (mean age, 19.85 yr; n = 67, 61 athletes, 6 nonathlete cadets) completed similar visits. Linear mixed models and general linear models tested associations of hormone levels and/or variation with concussion status, symptoms, and recovery, controlling for self-reported birth control use at pre-injury baseline. Results Female participants with concussion had higher progesterone levels relative to controls on average across all visits (mean difference (MD; ln ng·mL-1) (standard error) = 0.26 (0.08), t(193) = 3.03, P = 0.003). Those with concussion had elevated estradiol at 24 h (MD = 0.27 (0.09), t(506) = 3.04, P = 0.02), Init RTP (MD = 0.38 (0.09), t(508) = 4.29, P < 0.001), and PRTP (MD = 0.30 (0.09), t(515) = 3.25, P = 0.01) relative to pre-injury baseline and compared with controls at Init RTP (MD = 0.35 (0.12), t(429) = 2.78, P = 0.006). Concussed participants had a lower range of estradiol over 7-28 d than controls (B (SE) = -0.24 (0.09), F(1,145) = 6.43, P = 0.01). Acutely after concussion, estradiol was positively associated with Brief Symptom Inventory Global Severity Index scores (B (SE) = 0.29 (0.12), F(1,102) = 5.60, P = 0.02). No significant relationships were found between hormones and recovery. Conclusions These results, which warrant further research, suggest that ovarian hormones may be associated with concussion and psychological symptom severity post-concussion.
AB - Introduction Female athletes are underrepresented in concussion research, and few studies have investigated associations of ovarian hormones with concussion outcomes. This study explored associations of concussion with levels and variability of progesterone, estradiol, and their ratio (P/E) and examined relationships of hormone levels with clinical measures and recovery after concussion in CARE Consortium female athletes and cadets. Methods Female participants enrolled (n = 749) at pre-injury baseline. Participants with concussion (mean age, 19.34 yr; n = 130, 90 athletes, 40 nonathlete cadets) completed one or more visits at nonstandardized times of day: immediately post-injury, 24 h post-injury, upon initiating the return-to-play protocol (Init RTP), and 7 d following unrestricted return-to-play (PRTP). Controls (mean age, 19.85 yr; n = 67, 61 athletes, 6 nonathlete cadets) completed similar visits. Linear mixed models and general linear models tested associations of hormone levels and/or variation with concussion status, symptoms, and recovery, controlling for self-reported birth control use at pre-injury baseline. Results Female participants with concussion had higher progesterone levels relative to controls on average across all visits (mean difference (MD; ln ng·mL-1) (standard error) = 0.26 (0.08), t(193) = 3.03, P = 0.003). Those with concussion had elevated estradiol at 24 h (MD = 0.27 (0.09), t(506) = 3.04, P = 0.02), Init RTP (MD = 0.38 (0.09), t(508) = 4.29, P < 0.001), and PRTP (MD = 0.30 (0.09), t(515) = 3.25, P = 0.01) relative to pre-injury baseline and compared with controls at Init RTP (MD = 0.35 (0.12), t(429) = 2.78, P = 0.006). Concussed participants had a lower range of estradiol over 7-28 d than controls (B (SE) = -0.24 (0.09), F(1,145) = 6.43, P = 0.01). Acutely after concussion, estradiol was positively associated with Brief Symptom Inventory Global Severity Index scores (B (SE) = 0.29 (0.12), F(1,102) = 5.60, P = 0.02). No significant relationships were found between hormones and recovery. Conclusions These results, which warrant further research, suggest that ovarian hormones may be associated with concussion and psychological symptom severity post-concussion.
KW - CONCUSSION IN WOMEN
KW - HORMONAL CONTRACEPTIVES
KW - MILD TRAUMATIC BRAIN INJURY
KW - OVARIAN HORMONES
UR - http://www.scopus.com/inward/record.url?scp=85209088291&partnerID=8YFLogxK
U2 - 10.1249/MSS.0000000000003591
DO - 10.1249/MSS.0000000000003591
M3 - Article
C2 - 39501473
AN - SCOPUS:85209088291
SN - 0195-9131
VL - 57
SP - 524
EP - 534
JO - Medicine and Science in Sports and Exercise
JF - Medicine and Science in Sports and Exercise
IS - 3
ER -